Skip to main content
Kala Visvanathan, MD, Oncology, Baltimore, MD

Kala Visvanathan MD MHS

Breast Cancer, Cancer Genetics/Cancer Risk Assessment


Joint Appointment in Oncology

Join to view full profile
  • 201 North Broadway StreetViragh BLDG 10th FLBaltimore, MD 21287

  • Phone+1 410-955-8964

  • Fax+1 410-367-2194

Dr. Visvanathan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2001 - 2003
  • University of Sydney Faculty of Medicine
    University of Sydney Faculty of MedicineClass of 1989

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2003 - 2027

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries with Breast or Ovarian Cancer  
    Kala Visvanathan, MD, JAMA Psychiatry
  • Social Factors Matter in Cancer Risk and Survivorship  
    Kala Visvanathan, MD, Cancer Causes & Control

Press Mentions

  • Breast Cancer Myths vs. Facts | Verify
    Breast Cancer Myths vs. Facts | VerifyOctober 28th, 2022
  • Effects of Sleep Deprivation on Performance
    Effects of Sleep Deprivation on PerformanceAugust 8th, 2022
  • Statins Tied to Significantly Lower Death Rate from Ovarian Cancer
    Statins Tied to Significantly Lower Death Rate from Ovarian CancerJune 24th, 2020

Grant Support

  • K07 Preventive Oncology Academic AwardNational Cancer Institute2005–2009
  • The Breast And Ovarian Surveillance Service (BOSS) Cohort StudyNational Center For Research Resources2006–2007
  • The Validity Of Ductal LavageNational Center For Research Resources2005–2006
  • The Reliability Of Ductal LavageNational Center For Research Resources2005–2006

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: